CymaBay Therapeutics Inc.

Q4 2019 vs. Q1 2024 13F Holders

Period
Q4 2019
Q1 2024
Num holders
121
2
Total reported value, excl. options
$116 M
$21.1 k
Total shares, excl. options
59,162,910
650
Manager Q4 2019
Shares
Q1 2024
Shares
Diff Chg %